{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:47:57Z","timestamp":1793040477835,"version":"4.5.0"},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgG4 monoclonal anti\u2010CD47 for cancer immunotherapy resulted in anemia necessitating red cell (RBC) transfusions. Although the antibody readily binds to CD47 on RBCs, the mechanism underlying the anemia associated with IgG4 is poorly understood. We investigated samples from patients receiving Hu5F9\u2010G4 (magrolimab) with positive reactivity in compatibility tests using a monocyte\u2010monolayer assay (MMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design and Methods<\/jats:title>\n                    <jats:p>\n                      For RBC opsonization, patient plasma was diluted to avoid direct agglutination and to give a 4+ indirect antiglobulin test (IAT) and &gt;10\n                      <jats:sup>3<\/jats:sup>\n                      mean fluorescent intensity (MFI) by flow cytometry. Fc\u03b3 receptor blocking used F(ab\u2032)\n                      <jats:sub>2<\/jats:sub>\n                      antibodies. Antibody\u2010dependent cellular cytotoxicity (ADCC) used purified natural killer (NK) cells. Recombinant IgG4 anti\u2010K and polyclonal anti\u2010D were tested by MMA concurrent with blocking of CD47 with a deglycosylated antibody.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five of six samples showed significant erythrophagocytosis (phagocytosis index [PI]\u2009=\u200920\u201360; PI\u2009&gt;\u20095 clinically significant) with the exception having 30\u2010fold lower MFI. Phagocytosis was not increased in the presence of complement. Fc\u03b3 receptor blocking showed Fc\u03b3RI and Fc\u03b3RIIa were involved but not Fc\u03b3RIIIa, supported by negative results when tested for NK ADCC. IgG4 anti\u2010K also showed significant erythrophagocytosis (PI\u2009=\u200930). Blocking of CD47 increased phagocytosis, 1.7 to 3.9\u2010fold, respectively, of RBCs opsonized with IgG4 anti\u2010K or polyclonal anti\u2010D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IgG4 RBC antibodies, generally not considered clinically significant for transfusion, can result in erythrophagocytosis providing an explanation for anemia related to anti\u2010CD47 mediated by Fc\u03b3RI and Fc\u03b3RIIa. Enhanced phagocytosis of alloantibody\u2010coated RBCs with concurrent blocking CD47 suggests potential for enhanced complications for patients who develop RBC alloantibodies while receiving cancer therapies targeting CD47.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70111","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:46:42Z","timestamp":1770446802000},"page":"700-711","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["<scp>IgG4<\/scp>\n                    anti\u2010\n                    <scp>CD47<\/scp>\n                    : Erythrophagocytosis and potential transfusion complications"],"prefix":"10.1111","volume":"66","author":[{"given":"Kayluz Frias","family":"Boligan","sequence":"first","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Loriamini","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"},{"name":"Department of Laboratory Medicine and Pathobiology University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead B.","family":"Holton","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurleen","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Binnington","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Velliquette","sequence":"additional","affiliation":[{"name":"Immunohematology and Genomics Laboratory New York Blood Center Enterprises (NYBCe)  Rye New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-4593","authenticated-orcid":false,"given":"Connie M.","family":"Westhoff","sequence":"additional","affiliation":[{"name":"Immunohematology and Genomics Laboratory New York Blood Center Enterprises (NYBCe)  Rye New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8974-2451","authenticated-orcid":false,"given":"Donald R.","family":"Branch","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Centre for Innovation  Toronto Ontario Canada"},{"name":"Department of Laboratory Medicine and Pathobiology University of Toronto  Toronto Ontario Canada"},{"name":"Department of Medicine University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00073"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2022.100070"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.011"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v16.i3.108045"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02018"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2020.05.009"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.943"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/10732748231159706"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807315"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01794"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013338"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15397"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15142"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15033"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16009"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137345"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2022.100070"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib8020030"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00876-4"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13812"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13921"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001413"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15796"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2018.07.004"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13766"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.504"},{"key":"e_1_2_10_29_1","first-page":"348","volume-title":"Judd's methods in immunohematology","author":"Johnson ST","year":"2022"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb01268.x"},{"issue":"1","key":"e_1_2_10_31_1","first-page":"82","article-title":"Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte\u2010macrophage interaction with erythrocytes","volume":"11","author":"Gallagher MT","year":"1983","journal-title":"Exp Hematol"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1187"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1331"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/333568a0"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.6.2274"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2021.02.038"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03312-6"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgaf143"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13379"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-122793"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027222"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-25-0425"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-0917"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00871-z"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70321"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.10.007"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18367"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15887-z"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000413"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1087532"},{"key":"e_1_2_10_52_1","first-page":"637","article-title":"IgG subclass distribution of anti\u2010Rh, anti\u2010Kell and anti\u2010Duffy antibodies measured by sensitive haemagglutination assays","volume":"67","author":"Michaelsen TE","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017004671"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:17:24Z","timestamp":1789654644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/trf.70111"],"URL":"https:\/\/doi.org\/10.1111\/trf.70111","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"2025-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}